Related Experiment Video
Updated: Jul 16, 2025

09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.7K
Tumor-Infiltrating Lymphocyte Recognition in Primary Melanoma by Deep Learning Convolutional Neural Network
Filippo Ugolini1, Francesco De Logu2, Luigi Francesco Iannone2
1Section of Pathological Anatomy, Department of Health Sciences, University of Florence, Florence, Italy.
The American Journal of Pathology
|September 21, 2023
Summary
Artificial intelligence (AI) using a convolution neural network (CNN) accurately assesses tumor-infiltrating lymphocytes (TILs) in primary melanoma (PM). This AI-based TIL score is a reliable prognostic marker for patient outcomes.
Area of Science:
- Digital pathology
- Artificial intelligence in oncology
- Melanoma research
Background:
- Tumor-infiltrating lymphocytes (TILs) are crucial prognostic indicators in primary melanoma (PM).
- Standardized assessment of TILs is challenging with conventional methods.
- AI in digital pathology offers potential for automated and standardized TIL evaluation.
Purpose of the Study:
- To develop and validate a novel convolution neural network (CNN) for automated TIL assessment in PM.
- To establish an AI-based TIL density index (AI-TIL) for prognostic evaluation.
- To compare the performance of AI-TIL with conventional TIL assessment methods.
Main Methods:
- A CNN was trained and validated on 307 primary melanoma whole slide images (WSIs).
- The CNN classified tumor patches based on the presence or absence of TILs, generating an AI-TIL index.
- Performance was evaluated on an independent testing set for specificity and sensitivity.
Main Results:
- The CNN demonstrated high performance, achieving 100% specificity and sensitivity in TIL recognition on the testing set.
- The AI-TIL index showed strong correlation with conventional TIL evaluation and patient clinical outcomes.
- The AI-TIL index was identified as an independent prognostic marker for favorable outcomes in PM.
Conclusions:
- A fully automated AI-TIL assessment is superior to conventional methods for differentiating PM clinical outcomes.
- The developed AI-TIL index serves as a robust and independent prognostic marker.
- Further research is needed to create user-friendly tools for clinical integration of AI-TIL assessment.

